Laufs, Ulrich
University Hospital Leipzig
38 papers on CoChatORCID 0000-0003-2620-9323
Most cited papers
- Verified
The Diagnosis and Treatment of Hypertriglyceridemia
Parhofer, K. G., & Laufs, U. (2019) · Deutsches Ärzteblatt international
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 110
- Verified
Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials
Bays, H. E., Banach, M., Catapano, A. L., Duell, P. B., Gotto, A. M., Laufs, U., Leiter, L. A., Mancini, G. B. J., Ray, K. K., Bloedon, L. T., et al. (2020) · Journal of Clinical Lipidology
Lipoproteins and Cardiovascular HealthPharmacovigilance and Adverse Drug Reactions
Cited by 103
- Verified · note
Targeting RNA With Antisense Oligonucleotides and Small Interfering RNA in Dyslipidemias
Katzmann, J. L., Packard, C. J., Chapman, M. J., Katzmann, I., & Laufs, U. (2020) · Journal of the American College of Cardiology
Lipoproteins and Cardiovascular HealthRNA Interference and Gene Delivery
Cited by 99
- Verified
Age-related medication adherence in patients with chronic heart failure: A systematic literature review
Krueger, K., Botermann, L., Schorr, S. G., Griese-Mammen, N., Laufs, U., & Schulz, M. (2015) · International Journal of Cardiology
Medication Adherence and ComplianceHeart Failure Treatment and Management
Cited by 94
- Verified
Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis
Werner, C., Gensch, C., Pöss, J., Haendeler, J., Böhm, M., & Laufs, U. (2011) · Atherosclerosis
Telomeres, Telomerase, and SenescencePeroxisome Proliferator-Activated Receptors
Cited by 71
- Verified
Effects of endurance training on serum lipids
Fikenzer, K., Fikenzer, S., Laufs, U., & Werner, C. (2018) · Vascular Pharmacology
Cardiovascular and exercise physiologyPhysical Activity and Health
Cited by 67
- Verified
Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk
Laufs, U., Karmann, B., & Pittrow, D. (2016) · Clinical Research in Cardiology
Lipoproteins and Cardiovascular HealthBlood Pressure and Hypertension Studies
Cited by 59
- Verified
Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table
Mach, F., Visseren, F. L. J., Cater, N. B., Salhi, N., Soronen, J., Ray, K. K., Delgado, V., Jukema, J. W., Laufs, U., Zamorano, J.-L., et al. (2024) · Journal of Clinical Lipidology
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 57
- Verified
Strategien zur Verbesserung der Einnahmetreue von Medikamenten
Laufs, U., Böhm, M., Kroemer, H., Schüssel, K., Griese, N., & Schulz, M. (2011) · DMW - Deutsche Medizinische Wochenschrift
Medication Adherence and CompliancePharmacy and Medical Practices
Cited by 39
- Verified
Effects of Renal Sympathetic Denervation on Exercise Blood Pressure, Heart Rate, and Capacity in Patients With Resistant Hypertension
Ewen, S., Mahfoud, F., Linz, D., Pöss, J., Cremers, B., Kindermann, I., Laufs, U., Ukena, C., & Böhm, M. (2014) · Hypertension
Blood Pressure and Hypertension StudiesCardiovascular and exercise physiology
Cited by 26
- Verified
PCSK9-directed therapies: an update
Katzmann, J. L., & Laufs, U. (2024) · Current Opinion in Lipidology
Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism
Cited by 22
- Verified
Risk prediction with triglycerides in patients with stable coronary disease on statin treatment
Werner, C., Filmer, A., Fritsch, M., Groenewold, S., Gräber, S., Böhm, M., & Laufs, U. (2014) · Clinical Research in Cardiology
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 13
- Verified
Anti-PCSK 9 antibodies increase the ratios of the brain-specific oxysterol 24S-hydroxycholesterol to cholesterol and to 27-hydroxycholesterol in the serum
Lütjohann, D., Stellaard, F., Bölükbasi, B., Kerksiek, A., Parhofer, K. G., & Laufs, U. (2021) · British Journal of Clinical Pharmacology
Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism
Cited by 8
- Verified
Effects of inhibition or Deletion of PCSK9 (proprotein convertase subtilisin/kexin type 9) on intracerebral hemorrhage volumes in mice
Schlunk, F., Fischer, P., Princen, H. M. G., Rex, A., Prinz, V., Foddis, M., Lütjohann, D., Laufs, U., & Endres, M. (2020) · Stroke
Intracerebral and Subarachnoid Hemorrhage ResearchLipoproteins and Cardiovascular Health
Cited by 4
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free